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ffectiveness of Physical Counterpressure
aneuvers in Preventing Vasovagal Syncope
he Physical Counterpressure Manoeuvres Trial (PC-Trial)
ynke van Dijk, MD,* Fabio Quartieri, MD,† Jean-Jaques Blanc, MD,‡ Roberto Garcia-Civera, MD,§
ichele Brignole, MD, Angel Moya, MD,¶ Wouter Wieling, MD, PHD,*
n behalf of the PC-Trial Investigators
msterdam, the Netherlands; Reggio Emilia and Lavanga, Italy; Brest Cedex, France;
nd Valencia and Barcelona, Spain
OBJECTIVES In this study, we assessed the effectiveness of physical counterpressure maneuvers (PCM) in
daily life.
BACKGROUND There is presently no evidence-based therapy for vasovagal syncope. Current treatment
consists of explanation and life-style advice. Physical counterpressure maneuvers have been
shown to raise blood pressure and to control or abort vasovagal episodes in laboratory
conditions.
METHODS We performed a multicenter, prospective, randomized clinical trial, which included 223
patients age 38.6 (15.4) years with recurrent vasovagal syncope and recognizable prodromal
symptoms. One hundred and seventeen patients were randomized to standardized conven-
tional therapy alone, and 106 patients received conventional therapy plus training in PCM.
RESULTS The median yearly syncope burden during follow-up was significantly lower in the group
trained in PCM than in the control group (p  0.004). During a mean follow-up period of
14 months, overall 50.9% of the patients with conventional treatment and 31.6% of the
patients trained in PCM experienced a syncopal recurrence (p 0.005). Actuarial recurrence-
free survival was better in the treatment group (log-rank p 0.018), resulting in a relative risk
reduction of 39% (95% confidence interval, 11% to 53%). No adverse events were reported.
CONCLUSIONS Physical counterpressure maneuvers are a risk-free, effective, and low-cost treatment method
in patients with vasovagal syncope and recognizable prodromal symptoms, and should be
advised as first-line treatment in patients presenting with vasovagal syncope with prodromal
symptoms. (The PC-Trial; http://www.controlled-trials.com/isrctn/trial/45146526/0/
45146526.html; ISRCTN45146526) (J Am Coll Cardiol 2006;48:1652–7) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.059American College of Cardiology Foundation
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casovagal syncope is a common clinical condition, with an
stimated life-time prevalence of 35% (1–3). Although the
isorder is episodic in nature, it could be considered a
hronic disorder. Often symptoms occur over many years
ue to recurrences of episodes of (pre)syncope (1,2) and its
eleterious effects on quality of life (4,5).
Although a large variety of treatments have been pro-
osed, evidence-based treatment options for patients with
ecurrent episodes are absent (6,7). Current widely accepted
reatment consists of explanation of the underlying mecha-
ism, reassurance about the benign nature of the episodes,
ecognition of premonitory symptoms, and avoidance of
riggers, even though the effectiveness is not formally
From the *Department of Internal Medicine, Academic Medical Center, Amster-
am, the Netherlands; †Department of Interventional Cardiology, Ospedale S. Maria
uova, Reggio Emilia, Italy; ‡Department of Cardiology, Hospital de la Cavale
lanche, Brest Cedex, France; §Department of Cardiology, Hospital Clinico Uni-
ersitario Valencia, Valencia, Spain; Department of Cardiology, Ospedali del
igullio, Lavanga, Italy; and the ¶Department of Cardiology, Hospital General Vall
’Hebron, Barcelona, Spain. This study was supported by the Netherlands Heart
oundation (Grant 2003B156). For a list of the PC-Trial Investigators see the
ppendix.t
Manuscript received April 20, 2006; revised manuscript received June 6, 2006,
ccepted June 19, 2006.roven. Similarly, volume expansion by means of raised
ater and salt intake or medication is sometimes advised
6–8). The few randomized double-blind trials on vasoac-
ive drugs failed to show superiority over placebo (6,7,9,10).
he use of pacemakers in patients with serious complaints
as been of variable effectiveness (11,12).
Physical counterpressure maneuvers (PCM) have previ-
usly proven to be effective in stabilizing blood pressure in
atients with autonomic failure (13,14). Recently, Krediet
t al. (15) published reports on controlling or aborting
mpending vasovagal syncope by leg crossing and muscle
ensing (16,17). Brignole et al. (18) found a comparable
ffect of isometric arm counterpressure maneuvers. How-
ver, these results were based on a limited number of
atients in laboratory conditions. The evaluation of the
ffectiveness of PCM in preventing recurrent episodes of
asovagal syncope in real life was the main aim of the
resent trial. We assessed whether treatment of patients
ith vasovagal syncope with PCM reduces the yearly
yncope-burden and improves time to first recurrence when
ompared with treatment with current conventional
herapy.
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he PC-Trial (Physical Counterpressure Manoeuvres
rial) was a multicenter, prospective, longitudinal, random-
zed clinical trial.
tudy population. Patients age 16 to 70 years with recur-
ent vasovagal syncope and recognizable prodromal symp-
oms were eligible for inclusion. Patients were recruited in
5 worldwide medical centers with at least 100 to 200
atient admissions for syncope per year (Appendix).
Recurrent syncope was defined as at least 3 syncope
pisodes in the last 2 years or at least 1 syncopal spell and 3
re-syncopal episodes in the last year. Furthermore, to be
ble to apply PCM, patients had to have recognizable
rodromal symptoms for their episodes.
The diagnosis of vasovagal syncope was based on the
efinition of the guidelines of the European Society of
ardiology (ESC) (6,7). Pre-syncope was defined as near
oss of consciousness.
The diagnosis of vasovagal syncope was based on the
istory taking criteria extensively described in the guidelines
f the ESC (6,7). Briefly, the diagnosis was considered
ertain with a typical history with episodes triggered by
rolonged upright position, pain, or emotional events and
ccompanied by lightheadedness, sweating, pallor, and/or
ausea/vomiting. Patients also had to have a normal phys-
cal examination and electrocardiogram (ECG).
Either to confirm a clinical diagnosis, or to make the
iagnosis in patients in whom the initial evaluation was
nconclusive, tilt-table testing was performed. Tilt testing
onsisted of 60° passive tilting for 20 min, with an addi-
ional 15-min head-up tilt with a 0.4-mg nitroglycerin
hallenge when the passive tilt failed to induce syncope
6,19,20). Continuous recording of ECG and, when avail-
ble, non-invasive beat-to-beat arterial blood pressure was
erformed by means of the Finapres (Finapres Medical
ystems, Amsterdam, the Netherlands) or a similar device
6,7,21). A positive response was defined as the induction of
ither pre-syncope or syncope in the presence of bradycar-
ia, hypotension, or both. Positive tilt-table testing was
eported according to the VASIS (Vasovagal Syncope In-
ernational Study) classification (22). Patients with a certain
linical diagnosis and patients with suspected vasovagal
yncope and a positive tilt-table test with recognizable
ymptoms both were included in the study (23).
Exclusion criteria were: suspected or overt heart disease
ith a high likelihood of cardiac syncope; orthostatic
ypotension; episodes of loss of consciousness different from
yncope; vascular steal syndrome; patients psychologically,
Abbreviations and Acronyms
ESC  European Society of Cardiology
PCM  physical counterpressure maneuvers
PC-Trial  Physical Counterpressure Manoeuvres Trialhysically, or cognitively unable to participate; doubtful tompliance; inaccessibility to follow-up; unwillingness or
nability to give informed consent; pregnancy; or a life
xpectancy of 1 year.
tudy design. The recurrence risk in the conventionally
reated group was estimated at 40% (24). Based on earlier
xperience (15,18), it was expected that PCM would halve
he recurrence rate. With a power of 80% and a significance
evel of 0.05, a minimum of 82 patients in each group was
equired. To avoid underpowering because of loss of follow-
p, it was decided to include 220 patients in the study.
Patients were randomized to either optimal standardized
onventional therapy alone or optimal conventional therapy
lus additional training in PCM. To obtain concealment of
llocation, randomization was performed by an independent
ata manager with permuted block randomization stratified
er study center. Patients were blinded for the results of the
andomization and were all invited for an educational
ession.
Conventional therapy consisted of explanation of the
echanisms underlying vasovagal syncope and advice with
egard to lifestyle modification (i.e., avoidance of triggers,
ying down in case of symptoms, and increasing fluid and
alt intake). A leaflet, identical for all participating centers,
as used to guarantee standardized therapy. Both groups
eceived identical counseling information.
Patients assigned to the study arm (PCM) were trained in
sing maneuvers. They were advised to use leg crossing,
andgrip, or arm tensing as a preventive measure in situa-
ions in which he/she is known to be prone to vasovagal
yncope and immediately in case of prodromal symptoms.
eg crossing consisted of the crossing of legs combined with
ensing of leg, abdominal, and buttock muscles (15). Hand-
rip consisted of the maximal voluntary contraction of a
ubber ball, or any other available object, taken in the
ominant hand. Arm tensing consisted of the contraction of
he 2 arms by gripping 1 hand with the other and contem-
orarily abducting both arms (18). Patients were instructed
o maintain the maneuver they chose for the maximum
olerated time or until complete disappearance of symptoms
nd to move on to a second or third maneuver if needed.
he sequence of the maneuvers was left to the patients’
iscretion. The training session consisted of biofeedback
raining using a continuous blood pressure monitor (21).
ach maneuver was demonstrated and explained. The
aneuvers were practiced under supervision, with immedi-
te feedback of the recordings to gain optimal performance.
atients were instructed to breathe normally during the
aneuvers. Patients received a set of photos of the maneu-
ers, and were advised to practice the maneuvers regularly.
atients were unaware which part of the training was
onventional treatment and which part was the intervention
nder consideration.
ata collection. All patients were checked by their physi-
ian with visits at 1 and 12 months. Every 3 months
ollow-up took place either during a regular visit or by
elephone. To be able to obtain all follow-up data, physi-
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Maneuvers for Vasovagal Syncope October 17, 2006:1652–7ians were not blinded for the results of the randomization.
he maximum follow-up period was 18 months, the min-
mum 6 months. All patients received a logbook for regis-
ration of symptoms. Recurrences were handled by the
ttending physician in each center. All data were entered
nto an electronic case record form made available on the
nternet by an independent data manager. All entered data
ere checked at 3-month intervals by the study coordinator.
n case of incomplete or inconsistent data, the responsible
tudy center was contacted for additional information.
tatistical analysis. Analysis was performed on the princi-
le of intention-to-treat. Primary end point of the study was
otal burden of syncope recurrence; secondary end point was
ime to first recurrence.
Sociodemographic and clinical data were expressed as
ercentages for categorical data, mean (SD) for normally
istributed numerical data, and median (quartiles) for non-
ormally distributed numerical data. Differences in socio-
emographic and clinical data between 2 patient groups
ere tested using the chi-square test for categorical vari-
bles, an independent-samples t test for normally distrib-
ted numerical variables and a Wilcoxon signed rank test for
on-normally distributed variables.
The difference in syncope burden was compared using an
ndependent-samples t test. Time to first recurrence was
isualized using a Kaplan-Meier survival curve and com-
ared using a log-rank test and Cox proportional hazards
nalysis. The influence of personal characteristics on recur-
ence rate (gender, age, previous number of [pre]syncopal
pisodes, results of head up tilt, and use of maneuvers) was
nalyzed using multivariate Cox proportional hazards anal-
sis. Relative risk reduction and hazard ratios are expressed
ith 95% confidence intervals.
A p value of 0.05 was considered to indicate a statisti-
ally significant difference.
The study was approved of by the Medical Ethical
ommittee of the Academic Medical Center, Amster-
am (project number 03/033). All patients gave informed
onsent.
ESULTS
opulation. From March 1, 2003 to December 15, 2004,
23 patients were included in the study. Follow-up was
losed on September 1, 2005. One hundred and seventeen
52.5%) patients were randomized to conventional therapy,
nd 106 (47.5%) for training in PCM (Fig. 1). Seven
atients randomized to conventional therapy and 8 patients
n the PCM group were lost to follow-up. These patients (4
en) tended to be younger than the remaining patients
mean age 30.6  11.5 vs. 38.0  15.1 years; p  0.068),
ess often experienced situational syncope (0% vs. 22.6%;
 0.045), and less often saw black dots as a prodromal
ymptom (6.7% vs. 31.3%; p  0.044). Otherwise, the
atients lost to follow-up were similar to the remaining
tudy population. iThis resulted in 208 patients available for analysis (110 vs.
8). Patients were comparable on all personal and clinical
haracteristics (Table 1). Mean follow-up after randomiza-
ion was 14.1  5.1 months in the conventional treatment
roup and 14.4  5.1 months in the PCM group (p 
.734).
yncope burden. During follow-up, the patients in the
onventional treatment group reported a total number of
42 syncope episodes, while the patients in the PCM group
eported 76 syncope episodes. The median yearly number of
pisodes per patient (syncope burden) was 0.6 (0.0 to 1.3) in
he conventional treatment group and 0.0 (0.0 to 0.7) in the
CM group (p  0.004) (Fig. 2).
ecurrences. Fifty-six (50.9%) patients with conventional
reatment and 31 (31.6%) patients in the PCM group
xperienced a syncopal recurrence (p  0.005), resulting in
relative risk reduction of 0.36 (95% confidence interval
.11 to 0.53). The number of patients experiencing 1 or
ore pre-syncopal episodes during follow-up was similar in
oth groups (73.6% in conventional vs. 82.7% in PCM
roup; p  0.118).
Time to first recurrence among the patients experiencing
recurrent syncopal episode was similar in both groups with
.6  5.9 months in the conventional treatment group and
.8  4.5 in the PCM group, p  0.106. Overall syncope-
ree survival is displayed in the Kaplan-Meier curve (Fig. 3);
og-rank statistic p  0.018. The resulting hazard ratio was
.59 (95% confidence interval 0.38 to 0.92).
At multivariate main effects analysis, the effectiveness of the
aneuvers was independent from gender, age, previous num-
er of (pre)syncopal episodes, results of head-up tilt, and most
sed maneuver. Moreover, no difference between centers was
ound in the effectiveness of the maneuvers, when comparing
he number of patients with recurrences. Gender was an
Figure 1. Flow-chart of included patients.ndependent predictor of recurrences but did not affect the
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October 17, 2006:1652–7 Maneuvers for Vasovagal Syncopereatment effect: overall women had significantly more recur-
ences than men (47.8% vs. 30.0%; p  0.014).
aneuvers. Of the patients randomised to PCM, 82
77.4%) used 1 or more maneuvers during follow-up. Of the
atients that used maneuvers, arm tensing was the maneuver
f first choice in 36.0%, hand grip in 25.8%, and leg crossing
n 23.6%. The remaining 14.6% of the patients did not
refer any maneuver above the other.
Of the remaining 16 patients in the PCM group who
ever used maneuvers, 1 patient experienced syncope during
able 1. Personal and Clinical Characteristics of Patients
umber
ender (% male)
ge, yrs (mean [SD])
ighest educational level (%)
None
Elementary school
High school
College
o. of lifetime syncopal episodes (median [quartiles])
o. of syncopal episodes last 2 years (median [quartiles])
o. of pre-syncopal episodes last year (median [quartiles])
eriod of complaints, yrs (median [quartiles])
iagnosis by history taking (%)
riggers (%)
Instrumentation
Fear
Pain
Orthostatic
Situational
rodromal symptoms (%)
Nausea/vomiting
Sweating
Dizziness
Seeing black dots
Other
ead up tilt performed (%)
ead up tilt positive (%)
esults head up tilt test (%)
Mixed (type 1)
Cardioinhibitor (type 2)
Vasodepressive (type 3)
CM  physical counterpressure maneuvers.s
t
igure 2. Number of recurrences during follow-up. Black columns 
aneuvers; white columns  conventional therapy.ollow-up. Two others did experience pre-syncope during
ollow-up, but did not apply PCM.
Of the 31 patients that experienced syncope recurrence in
he PCM group, 11 patients (35%) had not used maneuvers
uring 1 or more recurrent episodes because of either
igure 3. Kaplan-Meier syncope-free survival curve of time to first
ventional Therapy PCM p Value
110 98
28.2 39.8 0.077
8.6 (15.4) 37.3 (14.6) 0.522
15.5 10.2 0.698
27.3 26.5
31.8 35.7
25.5 27.6
6 (3–12) 6 (4–12) 0.926
3 (2–5) 3 (2–6) 0.546
4 (2–7) 4 (2–13) 0.177
6.8 (2.1–22.1) 7.9 (1.6–20.9) 0.851
94.5 99.0 0.080
9.1 7.1 0.609
10.0 8.2 0.646
17.3 15.3 0.702
49.1 39.8 0.178
21.8 23.5 0.776
40.0 41.8 0.788
63.6 65.3 0.802
60.9 56.1 0.484
35.5 26.5 0.166
21.8 19.4 0.666
92.7 92.9 0.971
78.0 76.1 0.753
46.8 43.5 0.918
22.8 24.6
30.4 31.9Con
3yncopal recurrence. Log-rank statistic p  0.018; hazard ratio 0.59 (0.38
o 0.92). PCM  physical counterpressure maneuvers.
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Maneuvers for Vasovagal Syncope October 17, 2006:1652–7bsence of warning at all or too short duration of the
rodromal symptoms.
afety. During follow-up, no patient experienced any ad-
erse clinical outcomes related to syncope.
ISCUSSION
ffectiveness. This is the first randomized controlled trial
roviding an evidence-based treatment modality for vaso-
agal syncope (6,7). Physical counterpressure maneuvers are
n effective evidence-based treatment for patients with
ecurrent vasovagal syncope and recognizable prodromal
ymptoms. After training in PCM, patients experience
ewer syncopal episodes, and training in PCM reduces the
umber of patients with a recurrent syncopal episode by
6% during a mean follow-up period of 14 months. The
umber of patients needed to treat to prevent 1 patient from
xperiencing a syncope recurrence episode is 5 (quartiles 3 to
7). Our results advocate training in PCM to be first-line
herapy in patients presenting with vasovagal syncope with
ecognizable prodromal symptoms. The lifetime number of
pisodes and the prolonged period of complaints patients
ave (mean over 7 years) (Table 1) indicate that vasovagal
yncope in our study population can be considered a chronic
ondition that warrants this specific treatment (3).
Although maneuvers are not effective in all episodes in
rained patients, the majority of patients show a reduction in
he number of recurrences. The variable presentation of
pisodes probably causes the recurrences in these patients.
lthough recognizable prodromal symptoms were an inclu-
ion criterion, some patients did not experience or recognize
rodromal symptoms in every recurrent episode. Others had
oo short prodromal symptoms to apply the maneuvers.
arotid sinus massage has not been performed in all
atients. Especially in elderly patients, the presence of
omplex neurally mediated syncope, with a combination of
asovagal and carotid sinus syndrome, could be an explana-
ion for the variation in presentation and the ineffectiveness
f the maneuvers on some occasions. Furthermore, although
ot reported by patients in this study, patients could forget
o apply the maneuvers due to panic at the moment of
yncope or not remember the maneuvers. Practicing the
aneuvers regularly at home, therefore, should be advised
o all patients. Although patients were instructed to breath
ormally during the maneuvers, straining, causing a high
ntrathoracic pressure, and thereby reducing the blood flow
o the thorax could also have diminished the effectiveness of
he maneuvers in some patients (25).
In the conventional treatment group, the number of
atients with late recurrences (i.e., after 1 year of follow-up)
s large (Fig. 2), which is comparable to earlier findings (26).
n explanation for this finding can be that patients treated
onventionally avoid situations in which they are prone to
asovagal episodes and lie down in case of symptoms. After
symptom-free period, they may try to test these situationsgain. In the trained patients, the opposite might occur. mnowing that they have an effective method to prevent
pisodes from occurring they will try the maneuvers in
ituations in which they fainted at earlier occasions.
opulation. The study population consisted of more
omen than men (66.8% vs. 33.2%). This adequately
eflects the higher prevalence of vasovagal syncope in
omen (2,3). Recurrence was also more prevalent in
omen, which is in agreement with the earlier results
eported by Sheldon et al. (24). However, PCM were not
ore effective in women than in men. Number of
pisodes before presentation was, however, no predictor
or recurrences, which is in contrast with the results of
heldon et al. (24).
tudy limitations. A limitation of the study is that only
atients were blinded to the outcome of the randomization.
his study design was chosen to be able to perform the
raining of the maneuvers and assess the use of the maneu-
ers in case of symptoms. Although earlier laboratory
ndings proved the possibility to stop or postpone syncopal
pisodes (15,18,25), this design might have biased the
esults. To assess the true reduction in recurrences from
sing the maneuvers, a double-blind study with a “placebo”
rm could be performed, although the currently found effect
eems large enough to accept there is a true benefit of the
aneuvers above conventional therapy alone. Additionally,
e feel that both blinding of the doctors as well as a placebo
herapy may be almost impossible to perform in this kind of
tudy.
In the earlier studies by Krediet et al. (15) and Brignole et
l. (18), training in PCM resulted in even fewer syncopal
ecurrences. A possible explication for this difference could
e the intensity of the training during an impending faint in
heir studies.
In this study, patients were trained in the maneuvers
sing biofeedback with a continuous blood pressure moni-
or. This method is effective in many patients and allows the
atient to select the most effective of the various maneuvers
n a non-threatening situation.
The additional attention and confidence gained by the
isual effects during the training session would have pro-
ided an additional psychological treatment effect. Patients
andomized to conventional therapy, however, also received
n explanation of the diagnosis and life-style advice. Not
nowing the existence of additional treatment with maneu-
ers, this might have had a similar effect. Furthermore, it is
nown that vasovagal syncope can be triggered by a complex
ombination of physical and psychological stimuli (27). Any
eneficial effect of training in maneuvers, psychological or
hysical, is, therefore, inherent to the treatment and equally
seful.
No difference between centers was found in the effective-
ess of the maneuvers. It could be that the results are
ependent on the trainer instructing the patient. The
articipation of 15 worldwide centers in the study ruled out
his possibility. It can, therefore, be assumed that the
aneuvers are effective in patients trained in any center.
C
r
t
a
t
w
R
D
M
n
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
A
P
B
P
M
B
R
D
A
R
D
F
1657JACC Vol. 48, No. 8, 2006 van Dijk et al.
October 17, 2006:1652–7 Maneuvers for Vasovagal Syncopeonclusions. Physical counterpressure maneuvers are a
isk-free, effective, and low-cost treatment method in pa-
ients with vasovagal syncope with prodromal symptoms,
nd should be advised in combination with current conven-
ional therapy as first-line treatment in patients presenting
ith this syndrome.
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